Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

This French startup just raised $15M to make food out of mealworms

Add as a preferred source on Google

French startup Ynsect wants you to eat bugs — eventually. For now, it’s focusing on creating insect protein to feed farmed animals a healthier, more eco-conscious diet.

After raising just over $15 million in investment funding, Ynsect to expand its production capacity to produce 20,000 metric tons of insect protein each year. That’s a lot of bugs. Ynsect’s process starts by growing and farming mealworm larvae and turning it into a de-fatted protein meal to be used in animal feed and pet food. To supercharge this system, the company uses a mixture of robotics and artificial intelligence to grow the worms with the utmost efficiency.

Recommended Videos

Producing at a higher capacity means that Ynsect will be able to expand from selling its product primarily as feed to fish farms and into a larger animal market. And that has the potential to have a major impact on the agriculture industry.

“Few people today are aware of how the animals they eat have been fed,” Ynsect CEO Antoine Hubert said in a press release. “In fact, farmed animals mostly consume GM soya, grains, and sometimes poultry feather, as well as fish meal. It was the fish meal, in particular, which caught our attention.”

Fish meal is created from smaller fish, which are in danger of overfishing, Hubert said. “In turn, that’s causing severe depletion of ocean biodiversity, and leading to food safety concerns due to the high content of heavy metals which bio-accumulate within dwindling fish stocks.”

Ynsect’s insect protein is the company’s answer to that problem, given how sustainable the process in creating it is. The company uses all parts of the insect, creating very little waste. And after all, plenty of animals would already be eating insects in the wild.

With a total of $37 million in funding thus far — and certainly with more funding to come — Ynsect plans to expand eventually into human nutrition, nutraceuticals, and green chemistry. But don’t worry, that’ll come later. You don’t have to consume bugs just yet. For now, you can start by warming up to the idea of feeding bug-based, protein-rich food to your pets.

Nicole Carpenter
Former Digital Trends Contributor
Nicole is a freelance video game and tech writer from Massachusetts. She has a cat named Puppy.
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more